Status:
COMPLETED
The Impact of Genicular Nerves Chemical Neurolysis on the Quality of Life of Patients with Advanced Knee Osteoarthritis.
Lead Sponsor:
Poznan University of Medical Sciences
Conditions:
Osteo Arthritis Knee
Osteoarthritis
Eligibility:
All Genders
18-110 years
Phase:
PHASE4
Brief Summary
Genicular nerves chemical neurolysis in advanced osteoarthritis of the knee joint.
Detailed Description
The study aims to assess the safety and effectiveness of regional pain treatment methods and their impact on the quality of life of patients with advanced osteoarthritis of the knee joint.
Eligibility Criteria
Inclusion
- Patients of the Pain Treatment Clinic of the Transfiguration of Jesus Clinical Hospital of the Medical University of Poznań will be qualified for the study
- patients with gonarthrosis who failed to achieve satisfactory pain control (NRS\>3) despite the use of NSAIDs, Paracetamol, and co-analgesics
- Age of patients: from 18 to 110 years of age.
- Caucasian patients can give informed, complete, written consent.
Exclusion
- suspected or diagnosed opioid dependence syndrome
- active cancer
- dementia
Key Trial Info
Start Date :
October 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 14 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06087601
Start Date
October 17 2023
End Date
January 14 2025
Last Update
January 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Poznan University of Medical Sciences
Poznan, Poznań, Poland, 61-701